Bernstein Karen 4
4 · Ovid Therapeutics Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
Bernstein Karen
Director
Transactions
- Award
Stock Option (right to buy)
2025-02-20+45,000→ 45,000 totalExercise: $0.57Exp: 2035-02-19→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The option will vest in full on February 20, 2026, subject to the Reporting Person's continuous service through such vesting date.